ArticleBMC pharmacology & toxicology2026
Identifying key molecular interactions and pathways linking DEHP and its metabolite MEHP to allergic rhinitis: a network toxicology and molecular dynamics study.
Article in BMC pharmacology & toxicology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundDi-(2-ethylhexyl) phthalate (DEHP) and its major metabolite mono-(2-ethylhexyl) phthalate (MEHP) are ubiquitous environmental contaminants increasingly implicated in allergic rhinitis (AR). However, their molecular mechanisms remain unclear. This study aimed to employ a computational toxicology approach to predict DEHP/MEHP-associated toxicological targets and pathways relevant to AR and to screen for key mediators underpinning this association.
methodsPutative targets of DEHP and MEHP were compiled using SEA, SwissTargetPrediction, and TargetNet, while AR-related genes were curated from GeneCards, DrugBank, OMIM, DisGeNET, and PharmGKB. After deduplication, overlapping targets were analyzed via STRING-based protein–protein interaction (PPI) networks and GO/KEGG enrichment. Specifically, unique targets common to DEHP, MEHP, and AR were identified and prioritized. Expression of the core target was evaluated in the GSE52804 dataset (OVA-induced AR mouse model). Molecular docking assessed binding of DEHP/MEHP to PTGS2, followed by molecular dynamics (MD) simulations and free energy landscape (FEL) analyses.
resultsWe identified 370 unique predicted targets of DEHP/MEHP and 1,213 genes associated with AR, yielding 71 overlapping genes. Functional enrichment analysis of these overlaps suggested their potential involvement in inflammatory and immune pathways. Among these, 21 targets common to DEHP, MEHP, and AR were predicted to be associated with key biological processes such as cellular response to environmental stimulus. PPI network topology analysis indicated PTGS2 as a central hub gene. Molecular docking predicted moderate affinity for both ligands, with scores of − 6.4 for DEHP and − 7.6 for MEHP to PTGS2. MD simulations demonstrated the stability of both predicted complexes, with consistent binding free energies and the presence of persistent hydrogen bonds. FELs showed well-defined global minima for both complexes.
conclusionsThis in silico analysis predicts potential multi-target interactions between DEHP/MEHP and proteins implicated in AR pathogenesis. Among these, PTGS2 emerged as a high-priority candidate based on network topology and molecular docking evaluations. The computational results identify PTGS2 and other hub targets as candidates for experimental validation in the context of DEHP/MEHP exposure.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.